Conference Information

About Conference

Stroke 201 9 has been planning and aiming to stimulate new techniques for the treatment of neurodegenerative disorders and stroke that would be beneficial for the neurosurgery.

The conference will be organized around the theme ‘Current Breakthroughs & Novel Approaches in Neurodegeneration and Stroke’.

On behalf of the Stroke 201 9 committee, we are pleased to invite you to join the upcoming “8th International Conference on Neurodegenerative Disorders and Stroke” to be held during December 09-10, 2019 in Paris, France.

Pulsus Group

Pulsus Group is a medical journals publisher that publishes, promotes and disseminates the work of medical researchers in a manner that exemplifies the highest standards in research integrity. Pulsus group is in alliance with Germany and other medical research associations of international level. It publishes medical journals that emphasize medical specialties like Integrative Medicine, Cardiology, Surgery and Reproductive Medicine. Pulsus group is an association with prominent academic and research societies like Germany Society of Plastic Surgeons, German Society for Aesthetic Plastic Surgery and Germany Society for Surgery of the Hand.

Pulsus Group is an international level publisher in scientific, technical, and medical journals established within the year 1984 with offices in Ontario and Canada, India has reaped Andrew John publishing and openaccessjournals.com to expand its Open Access publishing through its 50+ journals in association with 20+ International medical and scientific societies.

Target Audience

Directors/Managers/CEO’s
Presidents & Vice Presidents
Neurologists
Neurosurgeons
Neurology doctors
Scientists and professors
Neuro research scholars
Medical Colleges
Research faculty
Academic Scientists
Students
Diagnostic laboratory professionals
Business Entrepreneurs
Industry professionals
Brand Manufacturers/ Marketers of Consumer Products
Marketing, Advertising and Promotion Agency Executives

Why should Attend

At the best conference, good innovative ideas are thrown about and new information is exchanged among scientific experts and this Conference may give a detailed Stroke study and current development in this field. Members around the world concentrated on learning about Neurodegenerative Disorders and Stroke, it is the best scientific platform to get more knowledge on Stroke.

Conference Opportunities

For Researchers and Faculty Members:

Speaker Presentations
Poster Display
Symposium hosting (4-5 members/team)
Workshop organizing

For Universities, Associations & Societies:

Association Partnering
Collaboration Proposals
Academic Partnering
Group Participation

For Students and Research Scholars:

Poster Competition (Winner will get Best Poster Award)
Young Researcher Forum (YRF Award to the best presenter)
Student Attendee
Group Registrations

For Business Delegates:

Speaker Presentations
Symposium hosting
Book Launch event
Networking opportunities
Audience participation

For Product Manufacturers:

Exhibitor and Vendor Booths
Sponsorships opportunities
Product launch Workshop organizing
Scientific Partnering
Marketing and Networking with clients

Benefits

Best Poster Award
Outstanding Young Researcher Award
Group Registration benefits
Keynote sessions by the world’s most eminent researchers
Top Industries Representations

Sessions & Tracks

Session 01: Neurodegenerative disorders

Name: Stroke 2019
Start: 2019-02-28
End: 2019-03-02
Location: France

Neurodegeneration is the progressive loss of structure or function of neurons, including the death of neurons. Many neurodegenerative diseases – including amyotrophic lateral sclerosis, Parkinson's, Alzheimer's, and Huntington's – occur as a result of neurodegenerative processes. Such diseases are incurable, resulting in progressive degeneration and/or death of neuron cells. Many neurodegenerative diseases are caused by genetic mutations, most of which are located in completely unrelated genes. Neurodegeneration can be found in many different levels of neuronal circuitry ranging from molecular to systemic.

Related conferences: International Conference on Alzheimers, Dementia and Related Neurodegenerative Diseases, December 03-04, 2018, Madrid, Spain | 8th International Conference on Neurology and Neuromuscular Diseases, January 28-29, 2019, Dubai, UAE | 3rd World Congress on Epilepsy and Neuronal Synchronization, February 25-26, 2019, Dubai, UAE | 2nd International Conference on Pediatric Neurology & Care, March 11-12, 2019, Berlin, Germany | 2nd Annual Congress on Advancements in Neurology and Neuroscience, March 11-12, 2019, Berlin, Germany | 4th International Conference on Neurology and Health Care, April 17-18, 2019, Amsterdam, Netherlands | 6th Annual Meeting on Neurosurgery and Neurological Surgeons, May 22-23, 2019, London, UK | World Congress on Neurochemistry and Neurophysiology, September 25-26, 2019, Dubai, UAE

Session 02: Neuroscience

The study of nervous system that deals with physiology, anatomy, molecular biology of neuron and neural networks is called neuroscience. Neuroscience is also called neurobiology. The homo sapiens brain contains around one hundred billion neurons and one hundred trillion synapses, it consists of thousands of distinguishable sub-structures, connected to each other in synaptic networks. The majority of the approximately 20,000–25,000 genes belonging to the human genome are expressed specifically in axons; axons is used to transmit electric signals from one to one another which is connected with the help of synapses. The other set are called dendrites is to receive the information which is transmitted by the axons.

Related conferences: World Congress on Spine and Spine Disorders, June 17-18, 2019, London, UK | 4th Annual Conference on Brain Disorders, Neurology and Therapeutics, July 15-16, 2019, Barcelona, Spain | 10^th International Conference on Dementia and Dementia Care, July 23-24, 2019, Rome, Italy | 2nd World Congress on Advances in Addiction Science and Medicine, July 23-24, 2019, Rome, Italy | World Congress on Parkinsons and Movement Disorders, July 23-24, 2019, Berlin, Germany | 3rd World Conference onNeurology and Therapeutics, August 28-29, 2019, Madrid, Spain | International Conference on Experimental Neurology and Cognitive Neuroscience, September 25-26, 2019, Dubai, UAE | Global Summit on Neurodegenerative Diseases: Biology & Therapeutics, October 21-22, 2019, Madrid, Spain

Session 03: Neuropathy

The general diseases or malfunctions of the nerves is normally referred to as neuropathy. It is classified according to the types or location of nerves that are affected by damage due to injury or disease. Neuropathy from the cause of diabetes is called Diabetic Neuropathy because it is most commonly associated with Diabetes. The symptoms of Neuropathy are loss of feeling in feet, Tingling, Extreme sensitivity to touch, paresthesia, loss of reflexes and cramping. Electromyography, nerve conduction velocity test (NCV) and nerve biopsy are the test and exam to diagnose Neuropathy. Antidepressants, Anticonvulsants, Opioids and Opioid-like drugs are the oral medications for neuropathy that have been successfully used to help the pain of neuropathy.

Session 04: Neurotherapy

Neurotherapy is the Kind of treatment for neurodegenerative disorders. The philosophy behind neurotherapy involves activating or deactivating to the organ(s), through pressure or massage on the nerve channels to stimulate or depress the blood, & other body fluids and the nerve currents. The therapy focuses at the cause not at the symptoms of the disease. This method has no side effects and no instruments get involved in this treatment.

Mentally retarded child, Paralysis, Joint Pain, Chronic constipation, tail bone pain, Depression, Vertigo, Piles, Obesity, Hypothyroid, Insomnia, Anal fistula, Cramps, Diabetes, Cervical spondylitis, Arthritis, Angina pectoris, Menses related problem, Tennis elbow, Swelling, hair falling, Tilt, Allergy, Gastric problem, Motor neuron disease. These are the diseases which is successfully treated by neurotherapy.

Related Conferences: World Congress on Spine and Spine Disorders, June 17-18, 2019, London, UK | 4th Annual Conference on Brain Disorders, Neurology and Therapeutics, July 15-16, 2019, Barcelona, Spain | 10^th International Conference on Dementia and Dementia Care, July 23-24, 2019, Rome, Italy | 2nd World Congress on Advances in Addiction Science and Medicine, July 23-24, 2019, Rome, Italy | World Congress on Parkinsons and Movement Disorders, July 23-24, 2019, Berlin, Germany | 3rd World Conference onNeurology and Therapeutics, August 28-29, 2019, Madrid, Spain | International Conference on Experimental Neurology and Cognitive Neuroscience, September 25-26, 2019, Dubai, UAE | Global Summit on Neurodegenerative Diseases: Biology & Therapeutics, October 21-22, 2019, Madrid, Spain

Session 05: Neurological Disorders

Neurological disorders are a type of disorders which means structural, biochemical and electrical abnormalities of brain, spinal cord or nerves in the nervous system. With the help of Neurology and Clinical Neuropsychology, these disorders can be studied and treated after neurological examination. There are two main broadest division called central nervous system disorders and Peripheral nervous system Disorders. The common symptoms of neurological disorders are paralysis, muscle weakness, poor coordination, loss of sensation, Seizures, Confusion, pain and altered levels of consciousness.

Related Conferences: International Conference on Alzheimers, Dementia and Related Neurodegenerative Diseases, December 03-04, 2018, Madrid, Spain | 8th International Conference on Neurology and Neuromuscular Diseases, January 28-29, 2019, Dubai, UAE | 3rd World Congress on Epilepsy and Neuronal Synchronization, February 25-26, 2019, Dubai, UAE | 2nd International Conference on Pediatric Neurology & Care, March 11-12, 2019, Berlin, Germany | 2nd Annual Congress on Advancements in Neurology and Neuroscience, March 11-12, 2019, Berlin, Germany | 4th International Conference on Neurology and Health Care, April 17-18, 2019, Amsterdam, Netherlands | 6th Annual Meeting on Neurosurgery and Neurological Surgeons, May 22-23, 2019, London, UK | World Congress on Neurochemistry and Neurophysiology, September 25-26, 2019, Dubai, UAE

Session 06: Etiology of stroke and Risk Factors

A stroke is developed when the blood supply to part of your brain is interrupted or blocked, depriving brain tissue of oxygen and nutrients. Within minutes, brain cells begin to die. A stroke may be caused by a blocked artery (ischemic stroke) or the leaking or bursting of a blood vessel. Many factors can increase your stroke risk.. Potentially treatable stroke risk factors include: Being overweight or obese, Physical inactivity, Heavy or binge drinking and cigarette smoking or exposure to second hand smoke, High cholesterol, and Diabetes.

Session 07: Preventive Stroke Strategies

Many stroke prevention strategies are the same as strategies to prevent heart disease. In general, healthy lifestyle recommendations include: Controlling high blood pressure (hypertension), Lowering the amount of cholesterol and saturated fat in your diet, Quitting tobacco use, Controlling diabetes, Maintaining a healthy weight, Eating a diet rich in fruits and vegetables, Exercising regularly, Drinking alcohol in moderation, if at all, Treating obstructive sleep apnea, Avoiding illegal drugs.

Session 08: Neuro Oncology

Neuro-Oncology is study of treatment for patients with cancers of the brain and nervous system. There are some of the conditions and symptoms which includes: Acoustic neuroma, Brain metastases, Astrocytoma, Chordoma, Ependymoma, Craniopharyngioma, Glioblastoma multiforme, Glioma, Lymphoma, Meningioma, Medulloblastoma, Oligodendroglioma, Brain tumors, Pineal tumor and Schwannoma.

Session 09: Stroke and Mental Health

A stroke is an emergency of medical aspect that requires early treatment that indicates early action can minimize brain damage and potential complications. Person affected by stroke addresses cognition and/or behavioral problems that includes problems using languages, vision and perception problems and sudden bursts of emotions.

Session 10: Dementia

Dementia is a syndrome characterized by cognitive or memory impairments that describes the symptoms of many conditions that affects the brain. The commonly seen conditions are Alzheimer’s and Parkinson’s disease. Symptoms seen at early stages are memory loss, personality changes, withdrawal and confusion.

Session 11: Hemorrhagic Stroke

Hemorrhagic stroke involves bleeding within the brain, which damages nearby brain tissue and there are two types of hemorrhagic stroke: intracranial hemorrhage (ICH), which occurs with bleeding into the brain tissue and subarachnoid hemorrhage (SAH), which occurs with bleeding into the subarachnoid space beneath the arachnoid mater of the meninges. Causes of hemorrhagic stroke include Aneurysms, arteriovenous malformation (AVM), and Cerebral amyloid angiopathy.

Related conferences: International Conference on Alzheimers, Dementia and Related Neurodegenerative Diseases, December 03-04, 2018, Madrid, Spain | 8th International Conference on Neurology and Neuromuscular Diseases, January 28-29, 2019, Dubai, UAE | 3rd World Congress on Epilepsy and Neuronal Synchronization, February 25-26, 2019, Dubai, UAE | 2nd International Conference on Pediatric Neurology & Care, March 11-12, 2019, Berlin, Germany | 2nd Annual Congress on Advancements in Neurology and Neuroscience, March 11-12, 2019, Berlin, Germany | 4th International Conference on Neurology and Health Care, April 17-18, 2019, Amsterdam, Netherlands | 6th Annual Meeting on Neurosurgery and Neurological Surgeons, May 22-23, 2019, London, UK | World Congress on Neurochemistry and Neurophysiology, September 25-26, 2019, Dubai, UAE

Session 12: Stroke Rehabilitation and Recovery

Stroke is one of the main leading causes of long-term adult disability which is affecting approximately 795,000 people each year in the USA. Someone who suffered a stroke can improve functions and sometimes remarkable recoveries by early recovery and rehabilitation. The goal of a stroke rehabilitation program is to help you relearn skills which are lost when stroke affected part of your brain. Stroke rehabilitation can help to regain independence and improve the quality of life.

Session 13: Pediatrics: Stroke and metabolic disorders

Stroke is more common in boys than girls even after controlling for differences in frequency of causes trauma and these appears to be a predominance of stroke in black children. This difference remains true even after accounting for sickle cell disease patients with stroke and moreover seizures are common in both ischemic and hemorrhagic strokes. They occur in up to 50% of children with strokes are not restricted to any age group and are not limited to any specific seizure type. A stroke or cerebral vascular accident (CVA) in children is typically considered to be a rare event. The reported incidence of combined and hemorrhagic ischemic pediatric stroke ranges from 1.2 to 13 cases per 100,000 children under 18 years of age.

Non-contrast head computed tomography (CT) is sensitive for acute bleeding and should be obtained emergently to exclude a cause for hemorrhagic stroke. Despite increasingly advanced imaging techniques the adult literature suggests that a lumbar puncture is still needed to rule out a subarachnoid hemorrhage.

Session 14: Neurosurgery

The Neurovascular surgery specializes in the management of complex central nervous system vascular disorders including arteriovenous malformations, aneurysms, cavernous angiomas, and carotid and intracerebral stenosis. Surgery and vascular procedures can be used to prevent stroke to treat or to repair damaged blood vessels or malformations in and around the brain. Carotid endarterectomy is a surgical procedure in which a surgeon removes fatty deposits or plaque from the inside of one of the carotid arteries and this procedure is performed to prevent stroke.

Session 15: Structural Biology

Structural biology is the study of molecular structure and dynamics of biological macro-molecules like proteins and nucleic acids, and how changes in their structures affect their function. Structural biology is the combination of the principles of molecular biology, biochemistry, and biophysics. Bio-molecules are too small to be viewed by even the advanced microscope. Large number of macromolecules assemblies have been reconstructed by fitting higher resolution crystal structures of individual components into lower resolution electron microscopy reconstruction of the entire complex.

Session 16: Current Breakthrough in Stroke Research

The randomized clinical research study shows a dramatic improvement in restoring blood back to the brain in arteries. This study involved minimally invasive clot procedure known as stent thrombectomy and this standard clot procedure called as tissue plasminogen activator. In patients with more severe strokes, each trail shows the striking benefit of catheter-based clot removal to restore blood flow in brain arteries. This can be used to improve the treatment for heart attacks known as acute stroke therapy. There is another new treatment for the stroke shown to be very effective that and it will be used as a part of standard stroke care.

Session 17: Clinical Trials & Case Reports

Clinical trials and case reports include the involvement of larger groups of people confirming the effectiveness of a drug or treatment, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely. This track gives researchers knowledge about new technologies, clinical trials and new aspects.

Market Analysis

SCOPE AND IMPORTANCE

Globally the market for stroke disorder & treatments increasing rapidly. The major factor that drives the growth of stroke disorder & treatment is the increasing high blood pressure patients. Ischemic stroke is caused by a dysfunction in the supply of blood to the brain due to emboli, thrombus or atherosclerosis occurring in cerebral arteries. According to a World Health Organization (WHO) estimate, around 17 million people die every year due to cardiovascular diseases. The statistics of the Centres for Disease Control and Prevention suggest that about 87% of all strokes are ischemic strokes. Moreover, stroke leads to 1 out of every 20 deaths, costing around $34 billion to the U.S. annually. Higher rates of mortality associated with strokes highlight an impending need for innovative drugs and diagnostic devices.

The two major factors propelling the growth of the acute ischemic stroke diagnosis and treatment market are; large patient pools and a concerning rise in population at a higher risk of developing stroke in the near future. Rising incidence of diabetes along with heavy tobacco users and an increase in the ageing population are significant factors that determine the market growth.

New Product launches and collaborations are some of the key strategies adopted by leading industry players. In March, 2015, FDA approved WATCHMAN, a left atrial appendage closure device designed to prevent stroke in patients with atrial fibrillation. Silk Road Medical, Inc. has launched an Anti-Stroke Enroute Device, a transcarotid neuroprotection system, designed to access the common carotid artery through a minimally invasive technique. NeuroVive Pharmaceutical AB, entered into collaboration with BBB Therapeutics, for development of the NVP014 drug candidate used in the treatment of ischemic strokes.

COMPANIES

Abbott Laboratories
Medtronic plc
Boston Scientific Corporation
Cordis Corporation
Koninklijke Philips N.V
GE Healthcare
Siemens AG
Stryker Corporation
Genentech, Inc. and Merck & Co., Inc.

WHY PARIS

Paris is the capital of France. Which is also known as the “City of Light” or the “City of Love, “Paris was most popular cities among travelers due to its streets culture, art, beauty, and history. Paris is a city that captures the hearts of millions every year with 7.4 million visitors. With an incomparable heritage of historic sites, iconic monuments, and attractions. The capital also offers the delighted cultural journey 2,185 monuments, 206 museums, and many other exceptional places and it has attractive cultural Louvre Museum, Picasso Museum, Palais Garnier, Luxembourg Palace. The economy of Paris is comprised of high finance, banking, and luxury tourist goods. Paris is located in northern France on both banks of the Seine River. Paris occupies a central position in the rich agricultural region known as the Paris Basin, the city ringed with the forests of beech and oak known as “lungs of Paris”. A capital city is not only the political and cultural capital of France despite which major financial and commercial center.

List of Universities carrying out research in Stroke in World

University of Florida

University of Eastern Finland

University of Victoria

University of Münster

Washington University School of Medicine

Beijing Tiantan Hospital of Capital Medical University

The Ohio State University

University of Florence

University Hospital Essen

University of Cambridge

University of Tübingen

Laval University

University of South Carolina

Past Conference Report

Stroke 2018 Report

Thanks to all our wonderful speakers, conference attendees, and Sponsors, Stroke 2018 Conference was our best ever!

6^th International Conference on Neurodegenerative Disorders and Stroke, hosted by the PULSUS Group was held during October 22-23, 2018 Vienna, Austria at Mercure Hotel Wien Westbahnhof Felberstrasse 4, 1150 Wien, Austria, with the theme “Novel approaches and Developments in Neurodegenerative Disorders and Stroke”. Benevolent response and active participation were received from the Editorial Board Members of Pulsus Journals as well as from the Scientists, Neurologists, Professors, Neurosurgeon & Neuroimaging Technician, Pharmaceutical Industries, Stroke associations & foundation, Stroke drug Industries, Researchers and Students from the fields of Neurologist.

The conference was initiated with a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The list included:

Esther Lim, Philadelphia College of Osteopathic Medicine, USA

Omer Dursun, Abant Izzet Baysal University, Turkey

George Buerte Puplampu, Children’s Health Centre, Ghana

Saif Awladthani, Royal Hospital, Oman

Zamaryalai Hakimi, King Amanullah Hospital, Kabul

With the grand success of Stroke 2018, PULSUS is proud to announce the "7^th International Conference on Neurodegenerative Disorders and Stroke” scheduled on Feb 28 - Mar 01, 2019 at Paris, France.

For more information please visit: https://stroke.cmesociety.com/2018